维普期刊资源整合服务平台（V6.5）

60篇 您的检索式：作者名="Advani RH"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas 显示文摘	Zelenetz AD Abramson JS Advani RH	2010	J Natl Compr Canc Netw2010，8，3：	1
2	Bruton tyrosine kinase inhibitor ibrutinib(PCI-32765)has significant activity in patients with relapsed/refractory B-cell malignancies显示文摘	Advani RH Buggy JJ Sharman JP	2013	J Clin Oncol2013，31，：	1
3	VAMP -7 mediates vesicular transport fromendosomes to lysosomes显示文摘	Advani RJ Yang B Prekeris R Lee KC Klumperman J Scheller RH	1999	J Cell Biol1999，146，4：	1
4	Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma显示文摘	Advani RH Homing S J Hoppe RT	2014	J Clin Oncol2014，32，9：	1
5	Comparison of con- ventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E- IPI) 显示文摘	Advani RH Chen H Habermann TM	2010	BrJ Haematol2010，151，2：	1
6	NCCN task force report positron emission tomography(PET)/computed tomography(CT) scanning in cancer显示文摘	Podoloff DA Advani RH Allred C		0，，1：	1
7	NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin' s lymphomas 显示文摘	Zelenetz AD Abramson JS Advani RH	2010	J Natl Compr Canc Netw2010，8，3：	1
8	Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin 显示文摘	Horwitz SM Advani RH Bartlett NL	2014	Blood2014，123，20：	1
9	NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer 显示文摘	Podoloff DA Advani RH Allred C	2007	J Natl Compr Cane Netw2007，51，：	1
10	NCCN Clinical Practice Guideline in Oneology: non-Hodgkin's lympho- mas 显示文摘	ZELENETZ AD ABRAMSON JS ADVANI RH	2012	J Natl Compr Canc Netw2012，，：	1
11	Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial显示文摘	Advani RH Hong F Homing SJ	2012	Leuk lymphoma2012，53，4：	1
12	Non-Hodgkin′sLymphomas显示文摘	Zelenetz AD Abramson JS Advani RH	2011	J Natl Compr Canc Netw2011，9，5：	1
13	Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies显示文摘	Advani RH Buggy J J Sharman JP	2013	J Clin Oncol2013，31，1：	1
14	Non-hodgkin,slymphoma显示文摘	Zelenetz AD Abramson JS Advani RH	2011	J Natl Compr Cane Netw2011，9，5：	1
15	NCCN Clinical Practice Guideline in Oncology:Non-Hodgkin's Lympho- mas 显示文摘	ZELENETZ AD ABRAMSON JS ADVANI RH	2012	J Natl Compr Canc Netw2012，，：	1
16	Cardiac toxicity associated with the anti- VEGF monoclonal antibody bevacizumab (Avastin) in combination with CHOP (A-CHOP) chemotherapy for peripheral T cell lymphoma (PTCL): the ECOG 2404 trial显示文摘	Advani RH Hong F Ganjoo KN	2009	Blood2009，114，22：	1
17	A constitutive rela-tionship for large deformation finite element modeling ofbrain Tissue显示文摘	Mendis KK Stalnaker RL Advani RH	1995	J Biomech Eng1995，117，3：	1
18	Hodgkin lymphoma 显示文摘	Hoppe RT Advani RH Ai WZ	2011	J Natl Compr Canc Netw2011，9，9：	1
19	NCCN ClinicalPractice Guidelines in Oncology:non-Hodgkin's lymphomas显示文摘	Zelenetz AD Abramson JS Advani RH	2010	J NatlCompr Canc Netw2010，8，3：	1
20	Bruton tyrosine kinase inhibitor ibrutinib(PCI-32765)has signi?cant activity in patients with relapsed/refractory Bcell malignancies显示文摘	Advani RH Buggy JJ Sharman JP	2013	J Clin Oncol2013，31，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示